Modified Zhenwu Decoction improved intestinal barrier function of experimental colitis through activation of sGC-mediated cGMP/PKG signaling
Journal of Ethnopharmacology · 2024
DOI: 10.1016/j.jep.2024.118570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2024. Verfasst von Yiqi Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Chinese Herbal Medicine Drug Development, Hong Kong Baptist University, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Mice, Inbred C57BL, Cyclic GMP, Signal Transduction. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province.
Abstract (Originalsprache)
BACKGROUND: The invasion of luminal antigens and an aberrant immune response resulting from a disrupted physical epithelial barrier are the key characteristics of ulcerative colitis (UC). The restoration of damaged epithelial function is crucial for maintaining mucosal homeostasis and disease quiescence. Current therapies for UC primarily focus on suppressing inflammation. However, most patients fail to respond to therapy or develop secondary resistance over time, emphasizing the need to develop novel therapeutic targets for UC. Our study aimed to identify the potential targets of a novel modified herbal formula from the Zhen Wu Decoction, namely CDD-2103, which has demonstrated promising efficacy in treating chronic colitis. METHODS: The effect of CDD-2103 on epithelial barrier function was examined using in vitro and ex vivo models of tissue injury, as well as a chronic colitis C57BL/6 mouse model. Transcriptomic analysis was employed to profile gene expression changes in colonic tissues following treatment with CDD-2103. RESULTS: Our in vivo experiments demonstrated that CDD-2103 dose-dependently reduced disease severity in mice with chronic colitis. The efficacy of CDD-2103 was mediated by a reduction in goblet cell loss and the enhancement of tight junction protein integrity. Mechanistically, CDD-2103 suppressed epithelial cell apoptosis and tight junction protein breakdown by activating the soluble guanynyl cyclase (sGC)-mediated cyclic guanosine monophosphate (cGMP)/PKG signaling cascade. Molecular docking analysis revealed strong sGC ligand recognition by the CDD-2103-derived molecules, warranting further investigation. CONCLUSION: Our study revealed a novel formulation CDD-2103 that restores intestinal barrier function through the activation of sGC-regulated cGMP/PKG signaling. Furthermore, our findings suggest that targeting sGC can be an effective approach for promoting mucosal healing in the management of UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Chinese Herbal Medicine Drug Development, Hong Kong Baptist University, Hong Kong SAR, China.
- Centre for Chinese Herbal Medicine Drug Development, Hong Kong Baptist University, Hong Kong SAR, China; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.
- Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, China.
- Centre for Chinese Herbal Medicine Drug Development, Hong Kong Baptist University, Hong Kong SAR, China; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China. Electronic address: hyhtan@hkbu.ed…
- Centre for Chinese Herbal Medicine Drug Development, Hong Kong Baptist University, Hong Kong SAR, China; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China. Electronic address: bzxiang@hkbu.e…
Förderung
- Special Project for Research and Development in Key areas of Guangdong Province
Zitieren
APA
Xu, Y., Huang, C., Xu, H., Xu, J., Cheng, K. W., Mok, H. L., Lyu, C., Zhu, L., Lin, C., Tan, H. Y., & Bian, Z. (2024). Modified Zhenwu Decoction improved intestinal barrier function of experimental colitis through activation of sGC-mediated cGMP/PKG signaling. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2024.118570
Vancouver
Xu Y, Huang C, Xu H, Xu J, Cheng KW, Mok HL, et al. Modified Zhenwu Decoction improved intestinal barrier function of experimental colitis through activation of sGC-mediated cGMP/PKG signaling. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2024.118570
BibTeX
@article{Xu2024,
author = {Xu, Yiqi and Huang, Chunhua and Xu, Hengyue and Xu, Jiaruo and Cheng, Ka Wing and Mok, Heung Lam and Lyu, Cheng and Zhu, Lin and Lin, Chengyuan and Tan, Hor Yue and Bian, Zhaoxiang},
title = {Modified Zhenwu Decoction improved intestinal barrier function of experimental colitis through activation of sGC-mediated cGMP/PKG signaling},
journal = {Journal of Ethnopharmacology},
year = {2024},
doi = {10.1016/j.jep.2024.118570}
}
EUVIMED